Enhanced Efficacy of Aurora Kinase Inhibitors in G2/M Checkpoint Deficient <i>TP53</i> Mutant Uterine Carcinomas Is Linked to the Summation of LKB1–AKT–p53 Interactions
Uterine carcinoma (UC) is the most common gynecologic malignancy in the United States. <i>TP53</i> mutant UCs cause a disproportionate number of deaths due to limited therapies for these tumors and the lack of mechanistic understanding of their fundamental vulnerabilities. Here we sought...
Main Authors: | Katherine N. Lynch, Joyce F. Liu, Nikolas Kesten, Kin-Hoe Chow, Aniket Shetty, Ruiyang He, Mosammat Faria Afreen, Liping Yuan, Ursula A. Matulonis, Whitfield B. Growdon, Michael G. Muto, Neil S. Horowitz, Colleen M. Feltmate, Michael J. Worley, Ross S. Berkowitz, Christopher P. Crum, Bo R. Rueda, Sarah J. Hill |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/9/2195 |
Similar Items
-
The Distinct Roles of LKB1 and AMPK in p53-Dependent Apoptosis Induced by Cisplatin
by: Tatsuya Shimada, et al.
Published: (2022-09-01) -
Beyond <em>LKB1</em> Mutations in Non-Small Cell Lung Cancer: Defining LKB1less Phenotype to Optimize Patient Selection and Treatment
by: Cristina Borzi, et al.
Published: (2020-11-01) -
The aurorae/
by: 223790 Harang, Leiv
Published: (1951) -
Reconsideration on the concept model of throat aurora
by: Desheng Han, et al.
Published: (2022-09-01) -
LKB1 suppression promotes cardiomyocyte regeneration via LKB1-AMPK-YAP axis
by: Shuang Qu, et al.
Published: (2022-09-01)